thymoquinone has been researched along with Obesity in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Hosseinzadeh, H; Kaviani, F; Mohsenzadeh, MS; Rameshrad, M; Razavi, BM | 1 |
Ghosh, S; Manchala, S; Raghunath, M; Sharma, G; Singh, AK; Sinha, JK | 1 |
Heart, EA; Karandrea, S; Liang, X; Slitt, AL; Yin, H | 1 |
Ghanem, M; Harphoush, S; Le, G; Qiuli, G; Shi, Y; Wu, G; Zaitoun, M | 1 |
Al-Abdin, OZ; Badr, G; Farhat, K; Mahmoud, MH; Rabah, DM; Waly, H | 1 |
Altunkaynak, BZ; Altunkaynak, ME; Kaplan, S; Tüfek, NH | 1 |
Heuberger, AL; Kester, AC; Reddivari, L; Vanamala, J | 1 |
2 review(s) available for thymoquinone and Obesity
Article | Year |
---|---|
Role of Phytomolecules in the Treatment of Obesity: Targets, Mechanisms and Limitations.
Topics: Adipokines; Animals; Anthocyanins; Anti-Obesity Agents; Benzoquinones; Catechin; Citrates; Drug Discovery; Drug Therapy, Combination; Energy Metabolism; Enzyme Inhibitors; Flavonoids; Humans; Lipids; Obesity; Phytochemicals; Phytohemagglutinins; Plant Extracts; Plants; Signal Transduction; Tannins | 2021 |
Mitigation of obesity-promoted diseases by Nigella sativa and thymoquinone.
Topics: Antioxidants; Benzoquinones; Cardiovascular Diseases; Chemoradiotherapy, Adjuvant; Humans; Insulin Resistance; Neoplasms; Nigella sativa; Obesity; Plant Extracts; Weight Loss | 2012 |
5 other study(ies) available for thymoquinone and Obesity
Article | Year |
---|---|
Thymoquinone attenuates olanzapine-induced metabolic disorders in rats.
Topics: AMP-Activated Protein Kinases; Animals; Benzoquinones; Glucose; Insulin Resistance; Leptin; Obesity; Olanzapine; Rats; Rats, Wistar | 2023 |
Thymoquinone ameliorates diabetic phenotype in Diet-Induced Obesity mice via activation of SIRT-1-dependent pathways.
Topics: Animals; Benzoquinones; Blood Glucose; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Hep G2 Cells; Humans; Insulin; Lipids; Male; Mice; Mice, Obese; Obesity; Phosphorylation; Sirtuin 1 | 2017 |
Thymoquinone ameliorates obesity-induced metabolic dysfunction, improves reproductive efficiency exhibiting a dose-organ relationship.
Topics: Animals; Antioxidants; Benzoquinones; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Fasting; Female; Lactation; Litter Size; Mammary Glands, Animal; Mice; Mice, Inbred C57BL; Mitochondria; Obesity; Oxidative Stress; Reproduction; Transcriptome | 2019 |
Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signaling.
Topics: Administration, Oral; Animals; Antioxidants; Benzoquinones; Blood Glucose; Body Weight; Cell Proliferation; Cytokines; Diabetes Mellitus, Experimental; Female; Free Radicals; Gene Expression Regulation; Hypoglycemic Agents; Lipid Metabolism; Litter Size; Lymphocytes; Mice; Obesity; Phosphatidylinositol 3-Kinases; Pregnancy; Proto-Oncogene Proteins c-akt; Signal Transduction | 2013 |
Effects of thymoquinone on testicular structure and sperm production in male obese rats.
Topics: Animals; Benzoquinones; Body Weight; Male; Obesity; Organ Size; Rats; Spermatozoa; Testis | 2015 |